SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...
SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...
(NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the top-line results of the NAVIGATE trial in patients with MASH cirrhosis and portal ...
In December 2020, Nasdaq proposed the following rules and sought SEC approval: Rule 5606: “Board Diversity Disclosure” Companies must disclose statistical information on a uniform matrix ...
Green board's 'faceless portal' to cut red tape, graft Vivek Ramaswamy leaves department of government efficiency, mulls run for Ohio governor The Printers Mysore Ltd ...